000 01601nam  2200349zi 4500
0019.892380
003CaOODSP
00520230217150627
006m     o  d f      
007cr bn|||||||||
008201013e19950430onc     ob   f000 0 eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aIu44-239/1995E-PDF
1001 |aAnderson, Malcolm,|d1961- |eauthor.
24510|aCompetition and the pharmaceutical value chain : |bcompetitive issues in the over-the counter and generic drug segments of the Canadian pharmaceutical industry : final report / |cQueen's Health Policy Team : Malcolm Anderson (Principal Investigator), Cindy Bolton, John Gordon, Steve Morgan, Bo Pazderka.
264 1|a[Ottawa] : |bIndustry Canada, |cApril 30, 1995.
300 |a1 online resource (77 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
500 |aDigitized edition from print [produced by Innovation, Science and Economic Development Canada].
504 |aIncludes bibliographical references (pages 75-77).
650 0|aPharmaceutical industry|zCanada.
650 0|aGeneric drugs|zCanada.
650 0|aDrugs|xLaw and legislation|zCanada.
650 6|aIndustrie pharmaceutique|zCanada.
650 6|aMédicaments génériques|zCanada.
650 6|aMédicaments|xDroit|zCanada.
7101 |aCanada. |bIndustry Canada, |eissuing body.
7102 |aQueen's University (Kingston, Ont.), |eissuing body.
85640|qPDF|s3.18 MB|uhttps://publications.gc.ca/collections/collection_2023/isde-ised/Iu44-239-1995-eng.pdf